XML 43 R5.htm IDEA: XBRL DOCUMENT v3.19.3.a.u2
Consolidated Statements of Equity - USD ($)
shares in Thousands, $ in Thousands
Total
Net Parent Investment
Member's Equity
Preferred Stock
Common Stock
Additional paid-in capital
Accumulated Deficit
Accumulated Other Comprehensive Income (Loss)
Beginning balance at Dec. 31, 2016 $ 23,320 $ 23,165 $ 0 $ 0 $ 0 $ 0 $ 0 $ 155
Beginning balance (in shares) at Dec. 31, 2016     0 0 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (138,187) (138,187)            
Other comprehensive income (loss) (21)             (21)
Net transfer from Parent Company 137,955 137,955            
Ending balance at Dec. 31, 2017 23,067 22,933 $ 0 $ 0 $ 0 0 0 134
Ending balance (in shares) at Dec. 31, 2017     0 0 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (138,139) (138,139)            
Other comprehensive income (loss) (52)             (52)
Net transfer from Parent Company 156,683 156,683            
Ending balance at Dec. 31, 2018 41,559 41,477 $ 0 $ 0 $ 0 0 0 82
Ending balance (in shares) at Dec. 31, 2018     0 0 0      
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (210,935) (89,258)         (121,677)  
Other comprehensive income (loss) (23)             (23)
Net transfer from Parent Company 106,119 106,119            
Contributions from Parent Company 56,310   $ 56,310          
Conversion from net parent investment into members' equity 0 (58,338) $ 58,338          
Conversion from net parent investment into members' equity (in shares)     100          
Conversion of member's equity into common stock (in shares)     (100)   114,790,438      
Conversion of members' equity into common stock 0   $ (114,648)   $ 12 114,636    
Stock-based compensation 2,535         2,535    
Issuance of common stock, net of costs (in shares)         1,924,402      
Issuance of common stock, net of costs 20,000         20,000    
Effect of reverse acquisition, net of costs (in shares)         79,286,198      
Effect of reverse recapitalization, net of costs 451,995       $ 8 451,987    
Ending balance at Dec. 31, 2019 $ 467,560 $ 0 $ 0 $ 0 $ 20 $ 589,158 $ (121,677) $ 59
Ending balance (in shares) at Dec. 31, 2019     0 0 196,001,038